Aaron Polliack

Q: What Schools Are Affiliated With Aaron Polliack

Aaron Polliack is affiliated with the following schools: Rockefeller University, University of California, San Francisco

Aaron Polliack's AcademicInfluence.com Rankings

Aaron Polliack

Philosophy

#6625

World Rank

#9689

Historical Rank

Logic

#3768

World Rank

#4976

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Aaron Polliack's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Aaron Polliack Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Aaron Polliack's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. (2015) (1185)
IDENTIFICATION OF HUMAN B AND T LYMPHOCYTES BY SCANNING ELECTRON MICROSCOPY (1973) (310)
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia (1976) (290)
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. (1996) (215)
Kidney involvement and renal manifestations in non‐Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients (2001) (210)
Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern (2001) (175)
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? (2006) (172)
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. (2017) (167)
Suppressive Effect of Ferritin on in Vitro Lymphocyte Function (1979) (161)
Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable. (1996) (148)
Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26–27 September 2011 and Menton 2011 consensus (2012) (133)
Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia (2006) (131)
Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010 (2010) (125)
Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma (2007) (123)
Morphological and immunophenotypic features of chronic lymphocytic leukemia. (2000) (120)
The late adverse events of rituximab therapy – rare but there! (2009) (118)
ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. (1999) (101)
The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT (2006) (98)
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options. (2013) (95)
Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3–5 October 2012 (2014) (93)
Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studies. (1995) (91)
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma. (2010) (91)
Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. (1981) (88)
CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies. (2003) (86)
Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. (2011) (84)
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era (2014) (81)
Absolute monocytosis at diagnosis correlates with survival in diffuse large B‐cell lymphoma—possible link with monocytic myeloid‐derived suppressor cells (2013) (78)
Scanning electron microscopy of murine macrophages. Surface characteristics during maturation, activation, and phagocytosis. (1975) (72)
Heparanase expression in human leukemias is restricted to acute myeloid leukemias. (2002) (71)
Potentiating effect of vitamin a on 9‐10 dimethyl 1‐2 benzanthracene—carcinogenesis in the hamster cheek pouch (1968) (70)
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination (2021) (68)
The incidence of lymphoma in first‐degree relatives of patients with Hodgkin disease and non‐Hodgkin lymphoma (2000) (67)
‘Hairy’ Cell Leukaemia (Leukaemic Reticuloendotheliosis): a Scanning Electron Microscopic Study of Eight Cases (1975) (66)
SCANNING ELECTRON MICROSCOPY OF HUMAN LYMPHOCYTE-SHEEP ERYTHROCYTE ROSETTES (1974) (63)
Ultrastructural Studies in β‐Thalassaemia Major (1973) (63)
Myeloid‐derived suppressor cells – their role in haemato‐oncological malignancies and other cancers and possible implications for therapy (2011) (62)
Pulmonary involvement in lymphoma. (1993) (62)
Report on the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19–20 September 2014 (2015) (60)
Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia (1980) (60)
Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome (2018) (54)
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches (2010) (54)
Surface morphology of murine B and T lymphocytes: A comparative study by scanning electron microscopy (1975) (53)
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia (2017) (52)
Widespread Castleman disease: CT and US findings. (1988) (52)
Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders. (2002) (52)
Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy (2015) (51)
Cancer patterns in the Middle East--special report from the Middle East Cancer Society. (1997) (51)
Conventional Dose Fludarabine-based Regimens are Effective but have Excessive Toxicity in Elderly Patients with Refractory Chronic Lymphocytic Leukemia (2003) (51)
The effect of topical vitamin A on papillomas and intraepithelial carcinomas induced in hamster cheek pouches with 9,10-dimethyl-1,2-benzanthracene. (1969) (51)
Acute promyelocytic leukemia with disseminated intravascular coagulation. (1971) (50)
CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma (2000) (50)
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL. (2014) (48)
Bendamustine associated immune suppression and infections during therapy of hematological malignancies (2016) (48)
Distribution of sialic acids on the red blood cell membrane in β thalassaemia (1978) (48)
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia (2021) (47)
Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration (2006) (45)
The fine structure of thymoma, with emphasis on its differential diagnosis. A study of ten cases. (1975) (45)
Scanning electron microscopy and the surface morphology of human lymphocytes (1978) (45)
Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis (2002) (45)
Insect‐bite‐like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group (2012) (44)
Early interim PET scan in Hodgkin lymphoma: Where do we stand? (2008) (44)
Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders. (1992) (44)
Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids. (1982) (44)
Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia (1980) (44)
Treatment of hairy-cell leukemia: current views. (1999) (44)
Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance. (2003) (44)
A scanning electron microscopic study of 34 cases of acute granulocytic, myelomonocytic, monoblastic and histiocytic leukemia. (1975) (43)
Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma (2003) (42)
Intravascular lymphomatosis--an indolent or aggressive entity? (1998) (41)
Fatal interstitial pneumonitis related to rituximab-containing regimen. (2006) (41)
The liver in amyloidosis. (1974) (41)
Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia. (1992) (40)
Increased CD39 expression on CD4+ T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia (2012) (40)
Quantitative flow cytometry of ZAP‐70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome (2006) (40)
Surface features of normal and leukemic lymphocytes as seen by scanning electron microscopy. (1975) (40)
Neutrophil‐lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients (2016) (39)
Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients. (2015) (39)
Enhancement of chemical carcinogenesis in the hamster cheek pouch by prior topical application of vitamin A palmitate. (1969) (38)
Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care. (2012) (37)
Immunofluorescent demonstration of enteropathogenic Escherichia coli in tissues of infants dying with enteritis. (1970) (37)
Association of a chromosomal abnormality with lymphocytes having both T and B markers in a patient with lymphoproliferative disease. (1976) (37)
The association of inflammatory bowel disease and leukemia--coincidence or not? (1995) (36)
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a patient with isolated renotesticular involvement after cure of non-Hodgkin's lymphoma (1997) (36)
Geography, ethnicity and “roots” in chronic lymphocytic leukemia (2013) (36)
Large‐cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine–rituximab‐containing regimens: natural history‐ or therapy‐related complication? (2002) (35)
Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group. (2014) (35)
Myeloid metaplasia of the central nervous system in patients with myelofibrosis and agnogenic myeloid metaplasia. Report of 3 cases and review of the literature. (1978) (34)
Coexistence of myelomonocytic leukemia and monoclonal gammopathy or myeloma. Simultaneous Presentation in Three Patients (1984) (34)
Syncytial variant of nodular sclerosing Hodgkin's disease. A new clinicopathologic entity (1990) (34)
Establishment in continuous culture of a T‐lymphoid cell line (HD‐Mar) from a patient with Hodgkin's lymphoma (1980) (34)
Non‐Hodgkin's lymphoma associated with pregnancy a report of six cases, with a review of the literature (1985) (33)
Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma – a population based study of 335 cases with neuroendocrine skin tumour (2012) (33)
T-Cell Lymphomas in South America and Europe (2012) (32)
Establishment and characterization of a new permanent cell line (GDM-1) from a patient with myelomonoblastic leukemia. (1982) (32)
Ultrastructural, cell membrane, and cytogenetic characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia. (1981) (32)
The T-cell nature of the lymphocytes in two human epithelial thymomas: a comparative immunologic, scanning and transmission electron microscopic study. (1975) (31)
SCANNING ELECTRON MICROSCOPY OF HAIRY CELLS IN HAIRY-CELL LEUKÆMIA (1974) (31)
Severe hepatitis B virus reactivation related to ibrutinib monotherapy (2017) (31)
Pulmonary involvement as the major manifestation of chronic lymphocytic leukemia. (1992) (31)
Prognostic Factors in Multiple Myeloma (1978) (30)
Two-way referral bias: evidence from a clinical audit of lymphoma in a teaching hospital. (1998) (30)
Epidemiology and environmental risk in hairy cell leukemia. (2015) (30)
Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma (2018) (30)
Nature and incidence of liver involvement in agnogenic myeloid metaplasia. (2009) (30)
Tumor Lysis Syndrome Following Treatment with 2-Chlorodeoxyadenosine for Refractory Chronic Lymphocytic Leukemia (1993) (30)
Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin. (2012) (29)
"Jumping translocation" in a 17-month-old child with mixed-lineage leukemia. (1991) (29)
Richter's transformation to diffuse large B‐cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group (2014) (29)
Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology. (2018) (29)
Scanning electron microscopy of tobacco mosaic virus-labeled lymphocyte surface antigens (1975) (28)
Burkitt's lymphoma presenting as acute leukemia (Burkitt's lymphoma cell leukemia). Report of two cases in Israel (1980) (28)
Exposure to phorbol diester (TPA) in vitro as an aid in the classification of blasts in human myelogenous and lymphoid leukemias: In vitro differentiation, growth patterns, and ultrastructural observations (1982) (28)
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas. (2012) (27)
Human prothymocytes. Membrane properties, differentiation patterns, glucocorticoid sensitivity, and ultrastructural features (1980) (27)
Pancytopenia with hypercellular bone marrow—a possible paraneoplastic syndrome in carcinoma of the lung: A report of three cases (1984) (27)
A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders. (2009) (27)
Discordant bone marrow involvement in non-Hodgkin lymphoma. (2016) (27)
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group (2014) (27)
Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target (2015) (27)
Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. (2015) (27)
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials. (2016) (26)
Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic options. (2005) (26)
Early‐mid treatment C‐reactive protein level is a prognostic factor in aggressive non‐Hodgkin’s lymphoma (2007) (25)
Systemic lupus erythematosus and chronic lymphocytic leukemia: rare coexistence in three patients, with comments on pathogenesis. (1992) (25)
Extramedullary hematopoietic tumors of the cranial dura mater. (1969) (24)
Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases (2013) (24)
Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia. (1980) (24)
Scanning electron microscopy of mycoplasmas adhering to erythrocytes (1980) (24)
Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity (1998) (23)
T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression (2005) (23)
Acute Promyelocytic Leukaemia: A Report of Five Cases with a Comment on the Diagnostic Significance of Serum Vitamin B12 Determination (1972) (22)
Mixed papillary and follicular carcinoma of the thyroid gland with stromal amyloid. (1970) (22)
Antineoplastic effect of chlorpromazine in chemical carcinogenesis in the hamster cheek pouch. (1972) (22)
Enhancing effect of excess topical vitamin A on Rous sarcomas in chickens. (1972) (22)
Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support. (2003) (22)
Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy. (2016) (21)
Analysis of the peanut agglutinin-binding site as a differentiation marker of normal and malignant human lymphoid cells. (1981) (21)
Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices. (2012) (21)
CNS involvement by non-Hodgkin's lymphoma. Response to a standard therapeutic protocol. (1984) (21)
Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia. (1998) (21)
A comparative study of human cell lines derived from patients with lymphoma, leukemia and infectious mononucleosis. Membrane properties, ultrastructure, and surface morphology (1977) (21)
The contribution of scanning electron microscopy in haematology: its role in defining leucocyte and erythrocyte disorders (1981) (21)
Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis (2013) (20)
Immunotactoid glomerulopathy with massive bone marrow deposits in a patient with IgM kappa monoclonal gammopathy and hypocomplementemia. (2001) (20)
Normal, Transformed and Leukemic Leukocytes (1977) (20)
Salvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas. (1999) (20)
Normal, transformed, and leukemic leukocytes: A scanning electron microscopy atlas (1977) (20)
Coexistent chronic myeloid leukemia and IgA monoclonal gammopathy: report of a case and review of the literature. (1980) (20)
Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemia (2011) (19)
Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITP) of 10 years duration after only two infusions of rituximab. (2002) (19)
Acute lymphoblastic leukemia. Its occurrence with hypereosinophilic syndrome' and bilateral spontaneous pneumothorax. (1978) (19)
An Electron Microscopic Study of the Nuclear Abnormalities in Erythroblasts in Beta‐Thalassaemia Major (1974) (19)
Primary ALK Positive Anaplastic Large Cell Lymphoma of the Pancreas (2003) (19)
Hookah (narghile) smoking: A new emerging cause of secondary polycythemia (2011) (19)
Erythrocytosis associated with multiple cutaneous leiomyomata: report of a case with demonstration of erythropoietic activity in the tumour. (2009) (19)
A new myelomonoblastic cell line (M20): analysis of properties, differentiation, and comparison with other established lines of similar origin. (1985) (19)
Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced ‘brakes’ on host immunity (2009) (19)
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study (2020) (18)
A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen? (2010) (18)
Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience (2015) (18)
Novel therapeutic options for relapsed hairy cell leukemia (2015) (18)
Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods. (1990) (18)
Inhibition of Chemical Carcinogenesis in the Hamster Cheek Pouch by Topical Chlorpromazine (1970) (17)
Advising patients on the use of non-herbal nutritional supplements during cancer therapy: a need for doctor-patient communication. (2013) (17)
Juvenile myeloid leukemia with fetal erythropoiesis (1972) (17)
The tumor necrosis factor family and correlation with disease activity and response to treatment in hairy cell leukemia (1999) (17)
Sudden onset deafness as a presenting manifestation of chronic lymphocytic leukemia. (1993) (17)
Bone marrow necrosis as the only manifestation of disseminated carcinomatosis. (1980) (17)
Value of lymphangiography in the staging of Hodgkin lymphoma. (1994) (17)
Activity of fludarabine in refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma--the Jerusalem experience. (1994) (17)
Farage, a Novel Early B Cell Lymphoma Cell Line with Trisomy 11 (1992) (17)
Use of multiparameter studies and scanning electron microscopy in the interpretation and attempted correlation of surface morphology with cell type in 135 cases of human leukemias. (1981) (17)
Adhesion, spreading and fragmentation of human megakaryocytes exposed to subendothelial extracellular matrix: a scanning electron microscopy study. (1986) (17)
Aberrant congenital dyserythropoietic anemia with negative acidified serum tests and features of thalassemia in a Kurdish family. (1978) (16)
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma (2010) (16)
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines (2021) (16)
Right ventricular outflow tract obstruction due to extrinsic compression by non-Hodgkin's lymphoma: importance of echocardiographic diagnosis and follow up. (1992) (16)
Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia (2017) (16)
Studies on the resorption of experimental amyloidosis. (1970) (16)
A Prospective, Randomized Study of Melphalan, Prednisone, Lenalidomide (MPR) versus Melphalan (200 Mg/M 2 ) and Autologous Transplantation (Mel200) in Newly Diagnosed Myeloma Patients: An Interim Analysis. (2009) (15)
Coexistence of gaucher disease and philadelphia positive chronic granulocytic leukemia (1982) (15)
Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on (2019) (15)
The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis (2012) (15)
Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia (2012) (15)
ULTRASTRUCTURE OF THE INCLUSION BODIES AND NUCLEAR ABNORMALITIES IN β‐THALASSEMIC ERYTHROBLASTS * (1974) (15)
Involvement of the mandible in Gaucher's disease. Report of a case with post-mortem findings. (1971) (14)
Rapidly progressive diffuse large B‐cell lymphoma with initial clinical presentation mimicking seronegative Wegener's granulomatosis (2004) (14)
Increased Incidence of Carcinoma induced by DMBA in the Hamster Cheek Pouch in response to Vitamin A (1967) (14)
Development and rapid dissemination of Merkel‐cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma (2002) (14)
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. (1995) (14)
Parameters affecting the in vitro maturation of human monocytes to macrophages. (1986) (14)
Rare coexistence of Rosai–Dorfman disease and nodal marginal zone lymphoma complicated by severe life-threatening autoimmune hemolytic anemia (2013) (14)
Secondary myelofibrosis with metastatic breast cancer simulating agnogenic myeloid metaplasia: report of a case and review of the literature. (1985) (13)
Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2‐chlorodeoxyadenosine therapy (2001) (13)
Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment. (2017) (13)
Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options. (1997) (13)
Granulocytic sarcoma (chloroma) of bone: the CT appearance. (1986) (13)
Large B-cell Lymphoma Manifesting as an Invasive Cardiac Mass: Sustained Local Remission after Combination of Methotrexate and Rituximab (2002) (13)
Prevalence of asbestos bodies in basal lung smears. (1968) (13)
Hairy cell leukaemia: effects of phorbol ester on cell morphology and adherence and comparison with other B-cell neoplasias. (2009) (13)
Electron microscopic x-ray microanalysis of normal and leukemic human lymphocytes. (1976) (13)
Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia (2003) (12)
ABL 1 Methylation Is a Distinct Molecular Event Associated With Clonal Evolution of Chronic Myeloid Leukemia (1999) (12)
Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan. (2007) (12)
PARACETAMOL-INDUCED THROMBOCYTOPENIA AND HÆMOLYTIC ANÆMIA (1978) (12)
Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome. (2018) (12)
Hairy cell leukemia: Uncommon clinical features, unusual sites of involvement and some rare associations. (2015) (12)
Spontaneous rupture of the spleen in amyloidosis. (1972) (12)
Surface features of leukaemic megakaryocytic precursors. A study of 5 cases of megakaryoblastic leukaemia with scanning electron microscopy. (2009) (12)
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia (2017) (12)
Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel (2011) (12)
Scanning electron microscopy of mitogen-transformed human lymphocytes. (1975) (12)
SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course (2016) (12)
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group (2020) (12)
A “PET” topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end (2015) (12)
Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma (2016) (12)
Surface features and ultrastructure of isolated Kupffer cells as seen by scanning and transmission electron microscopy. (1978) (11)
Benign and Malignant Lymphadenopathies: Clinical and Laboratory Diagnosis (1993) (11)
Lymphopenia a simple prognostic factor in lymphoma and other cancers: why not use it more as a guide? (2010) (11)
Hypophosphatemia in a patient with lymphoma in leukemic phase. (1981) (11)
Cervical Lymph Node Metastasis of Hamster Cheek Pouch Carcinoma Induced with DMBA (1970) (11)
Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells (2002) (11)
Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study (2011) (11)
Coexistence of Chronic Lymphocytic Leukemia and Essential Thrombocythemia (2003) (11)
Characteristic Surface Morphology of Human and Murine Myeloma Cells: a Scanning and Transmission Electron Microscopic Study (1978) (11)
Benign mucous membrane pemphigoid with laryngeal stenosis in a patient with thyroid carcinoma. (1968) (11)
Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity. (2018) (11)
Altered surface morphology of Concanavalin A transformed thymic lymphocytes as seen by scanning electron microscopy. (1976) (11)
Secondary leukemia following treatment of Hodgkin's disease: ultrastructural and cytogenetic data in two cases with a review of the literature. (1983) (11)
Divergence in CD19-Mediated Signaling Unfolds Intraclonal Diversity in Chronic Lymphocytic Leukemia, Which Correlates with Disease Progression (2013) (11)
Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study. (1998) (10)
Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma. (2002) (10)
Late therapy-induced cardiac and pulmonary complications in cured patients with Hodgkin's disease treated with conventional combination chemo-radiotherapy. (1995) (10)
Fludarabine monophosphate reduces the incidence and severity of graft-versus-host disease in a murine model of bone marrow transplantation. (1997) (10)
B‐lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule (2000) (10)
Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association? (1978) (10)
Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients (2012) (10)
Amegakaryocytic Thrombocytopenia and Subsequent Aplastic Anemia Associated with Apparent Epstein-Barr Virus Infection (2018) (10)
Lymphoma and systemic sclerosis — an uncommon association or possible coincidence of two disorders with a fatal outcome (1997) (10)
The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia (2017) (10)
Surface morphology and membrane phenotype of cultured human leukemia‐lymphoma cells: A scanning electron microscopic study of 36 cell lines (1983) (10)
Unexpected detection of monoclonal B‐cell lymphocytosis in a HLA‐matched sibling donor on the day of allogeneic stem cell transplantation for a patient with chronic lymphocytic leukaemia: clinical outcome (2010) (9)
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab (2018) (9)
Changes in the Con-A-induced redistribution pattern of lymphocytes: a possible aid in the differential diagnosis between malignant lymphoma and other diseases. (1980) (9)
Myelomonocytic antigens are rarely expressed on B-lymphocytic leukemia cells. (1993) (9)
Solitary intracranial chloroma in a patient with chronic granulocytic leukemia (1983) (9)
Epithelial atypia in the hamster cheek pouch, induced by topical application of vitamin A. (1968) (9)
Plasma cell leukemia and myeloma: a scanning electron-microscopic study of cell surface features in six cases. (1981) (9)
Simultaneous presentation of plasma cell and monocytic leukemia with a subacute clinical course. (1982) (9)
Incidence and epidemiology of non‐Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow‐up (2017) (9)
Correlation of cytologic smear and histologic findings during 9-10 dimethyl 1-2 benzanthracene-induced carcinogenesis in the hamster cheek pouch. (1967) (9)
Randomized, multicenter, open-label, phase III study of the BTK inhibitor ibrutinib versus chlorambucil in patients 65 years or older with treatment-naive CLL/SLL (RESONATE-2, PCYC-1115-CA). (2013) (9)
The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia (2017) (9)
Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia? (2011) (9)
Serum interleukin 1 beta levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels. (1994) (9)
Distribution of sialic acids on the red blood cell membrane in beta thalassaemia. (1978) (9)
Burkitt's lymphoma cells: membrane properties and surface morphology as seen by scanning electron microscopy. (1979) (8)
The effect of oestrogen on 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced cheek pouch carcinoma in castrated and non-castrated male Syrian golden hamsters. (1969) (8)
Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells. (2005) (8)
Plasmacytoma of the breast (1989) (8)
Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine-rituximab. (2003) (8)
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel (2018) (8)
Bell's palsy as a sign of Burkitt's lymphoma in children [letter] (1995) (8)
Phorbol esters and hairy cell leukemia: effects on cell morphology and surface membrane features and comparison with other B cell leukemias. (1987) (8)
The contribution of multiple data sources to a clinical audit of lymphoma in a teaching hospital. (1998) (8)
Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphoma. (2013) (8)
Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study (2021) (8)
Late cardiovascular and pulmonary complications of therapy in Hodgkin's disease: report of three unusual cases, with a review of relevant literature. (1992) (8)
Alteration in lymphocyte surface morphology and membrane fluidity induced by cholesterol depletion. (1979) (8)
Chronic T cell lymphocytosis with large granular lymphocytes of helper (OKT4) phenotype. (2009) (8)
Bell's palsy as a sign of Burkitt's lymphoma in children. (1995) (8)
Effect of topical cyclophosphamide, methotrexate and vinblastine on 9,10-dimethyl-1,2-benzanthracene (DMBA)--carcinogenesis in the hamster cheek pouch. (1970) (8)
Acute lymphoblastic leukemia. Association with vasopressin-responsive diabetes insipidus. (1980) (8)
Hypereosinophilia, JAK2V617F, and Budd‐Chiari syndrome: Who is responsible for what? (2011) (8)
Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations. (2014) (7)
Expression of CD11a (LFA-1) on B-chronic Lymphocytic Leukemia and Lymphoma Cells: Correlation with Cell Surface Immunoglobulin Intensity and CD58 (LFA-3) Expression. (1991) (7)
Cold urticaria: an unusual manifestation of histiocytic lymphoma. (1982) (7)
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma. (1994) (7)
Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study. (2012) (7)
Obstructive solitary bronchial non-Hodgkin's lymphoma--a rare presentation of primary extranodal disease. (1992) (7)
Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients. (1986) (7)
Multiple myeloma terminating in lymphocytic leukemia with B‐lymphocyte membrane markers (1977) (7)
In vitro differentiation and establishment of cell lines derived from human myelomonocytic leukemia cells. (1986) (7)
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan (2015) (7)
Defining the best cut‐off value for lymphopenia in diffuse large B cell lymphoma treated with immuno‐chemotherapy (2014) (7)
Bone lesions in hairy cell leukemia: Diagnosis and treatment (2020) (7)
Familial Lymphomas A review of the literature with report of cases in Jerusalem. (1990) (7)
Plasma cell leukemia. Unassembled light and heavy chains in the urine. (1974) (7)
Oral idarubicin in elderly acute leukemia and refractory anemia with excess of blasts. (1990) (7)
Chronic Lymphocytic Leukemia in Young Adults: Report of Six Cases Under the Age of 30 Years. (1991) (7)
Panuveitis responsive to 2-CdA: an unusual ocular presentation of hairy cell leukemia. (1996) (7)
Suspected Richter transformation: positron emission tomography/computed tomography tells us who should have a biopsy and where (2014) (7)
Current therapeutic options for subgroups of chronic lymphocytic leukemia. Planning risk-adapted treatment according to recognized prognostic factors. (2003) (7)
The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models (2000) (7)
Primary lymphoma of the esophagus in a patient with AIDS. (1995) (7)
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. (1993) (6)
Prognostic factors in multiple myeloma: a retrospective study using conventional statistical methods and a computer program. (1978) (6)
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma. (1993) (6)
Surface morphology of lymphoreticular cells: review of data obtained from scanning electron microscopy. (1978) (6)
Extramedullary multiple myeloma: extraosseous relapse is extra “bad news,” but why? (2013) (6)
Surface features of Sezary cells: A scanning electron microscopy study of 5 cases. (2009) (6)
Positive identification of human leukaemic cells with scanning immuno-electron microscopy, using antibody coated polystyrene (latex) beads as markers. (2009) (6)
Low‐dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD‐FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience (2019) (6)
Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation. (1987) (6)
A handbook of essential drugs and regimens in hematological oncology (1991) (6)
CD30+ expression in Peripheral T-cell lymphomas (PTCLs): A subset analysis from the international, prospective T-Cell Project. (2015) (6)
Surface topography of hairy cell leukemia cells compared to other leukemias as seen by scanning electron microscopy (2011) (6)
Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment (2018) (6)
Paracetamol-induced thrombocytopenia and haemolytic anaemia. (1978) (6)
Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlorodeoxyadenosine therapy: the spleen as a sanctuary site in HCL? [letter] (1994) (6)
Prothymocytes in postirradiation regenerating rat thymuses: a model for studying early stages in T cell differentiation. (1983) (6)
Complete spontaneous regression of chronic lymphocytic leukemia. (2012) (6)
Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells. (1997) (6)
The use of scanning immuno-electron microscopy to detect surface membrane immunoglobulins and antigens on normal and leukemic human leukocytes: current status. (1983) (6)
Scanning electron microscopy and the surface morphology of human leukocytes: current status. (1979) (6)
JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood counts. (2013) (5)
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases (2021) (5)
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival (2018) (5)
Surface markers and other characteristics of the lymphocyte in chronic lymphocytic leukemia. (1976) (5)
Cultured Cell Lines (1977) (5)
Hairy cell leukemia: report of an unusual case with hepatomegaly due to a large vascular tumor of the liver, mediastinal mass and pleural effusion containing hairy cells. (1984) (5)
Virus-cell interactions as seen by scanning electron microscopy. (1979) (5)
Bone marrow curettage in myelodysplastic disorders. A stimulus for regeneration in disturbed hematopoiesis. (1981) (5)
Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemia. (2015) (5)
Surface morphology and ultrastructure of isolated hepatic Kupffer and endothelial cells. (1978) (5)
STATEMENT OF RETRACTION (2013) (5)
Neurotoxicity with Leukoencephalopathy after a Single Intravenous High Dose of Methotrexate in a Patient with Lymphoma (2002) (5)
Associations between multiple myeloma and other malignancies (2011) (5)
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain (2019) (5)
Two cases of agranulocytosis associated with cocaine use: is this phenomenon becoming more prevalent? (2010) (5)
Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials (2018) (5)
Prolymphocytic leukaemia: surface morphology in 21 cases as seen by scanning electron microscopy and comparison with B‐type CLL and CLL in ‘prolymphocytoid’ transformation (1984) (5)
B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn (2013) (5)
Heterogeneity in TPA-induced differentiation of B-chronic lymphocytic leukemia cells: development of hairy cell or plasmacytoid features are time and dose dependent. (1987) (5)
Hairy Cell Leukemia, an Ultrastructural Study with Double Immunogold Labeling (1992) (5)
Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem. (1994) (4)
Fatal Shigella dysentery complicated by toxic megacolon and bone marrow aplasia in a patient with chronic granulocytic leukemia in remission. (1980) (4)
A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents (2021) (4)
Lysosomal enzyme studies in experimental amyloidosis of mice treated with cortisone. (1973) (4)
Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases (2020) (4)
Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly (2011) (4)
Are Absolute Monocyte Count and The Lymphocyte-Monocyte Ratio (LMR) Valid Prognostic Factors In Classical Hodgkin Lymphoma? An Evaluation Based On Data From 1079 Patients (2013) (4)
Hodgkin's disease and subsequent chronic lymphocytic leukemia in a patient with breast carcinoma. (1978) (4)
Projeto de célula-T: estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo (2009) (4)
Resorption of amyloid and enzymatic studies in amyloidosis. (1973) (4)
Impact of therapy on the development of second malignancies in essential thrombocythemia and polycythemia vera: Are we comfortable about this? (2015) (4)
A matter of life or early death in CLL: do serum immunoglobulin levels really count? (2016) (4)
Five Ibrutinib-Associated Side Effects That All Clinicians Should Be Aware of (2019) (4)
Discrepancies in quantitative assessment of bone marrow involvement in lymphoma: Do they reflect specialized micro-environmental cellular niches and cell-stromal interactions? (2006) (4)
Surface features of vaccinia virus-infected human embryonic cells as studied by scanning electron microscopy. (1977) (4)
Disseminated intravascular coagulation in two patients with histiocytic medullary reticulosis. (1984) (4)
Surface Features of Leukemic Cells (1977) (4)
Phorbol ester (TPA)-induced surface membrane alterations in B-type hairy cell and lymphocytic leukemia cells. (1986) (4)
Short- and Long-Term Responses of DMBA-Induced Hamster Cheek Pouch Carcinoma to a High Dose of Radiation (1971) (4)
Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence? (2016) (4)
Myelomatosis after phenytoin therapy: a chance association? (2009) (4)
The effect of cortisone on the formation and resorption of experimental amyloid. (1973) (4)
Development of polycythemia vera in a patient with myeloid metaplasia and myelofibrosis. Report of a case with a comment on its significance in relation to prevailing views on myeloid metaplasia. (1971) (4)
9,10-dimethyl-1,2-benzanthracene carcinogenesis in the hamster cheek pouch. Inhibitory effect of topically administered cortisone acetate. (1970) (4)
Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients. (1977) (4)
On the maturation rate of the neutrophil (1984) (4)
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting. (2021) (3)
Pegfilgrastim Prophylaxis for Cladribine-Induced Neutropenia in Patients with Hairy-Cell Leukemia (2014) (3)
Scanning electron microscopy of human leukocytes. A comparison of air dried and critical point dried cells. (1974) (3)
[Thalassemia minor and iron deficiency anemia among Israeli soldiers]. (1986) (3)
Sorafenib – a small molecule with big promise? (2010) (3)
A novel translocation (1;2)(p34;p21-22) in acute myelomonoblastic leukemia. (1998) (3)
Primary lymphoma of the parotid gland: a report of twelve cases with a review of the literature. (1991) (3)
Lymphoma-like lesions induced in the hamster cheek pouch with topical vitamin A palmitate. (1969) (3)
Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care. (2012) (3)
Hairy cell leukemia: reevaluation of cell surface features under the scanning electron microscope, using the "GTGO" air drying and critical point drying procedures. (1985) (3)
Ocular adnexal mucosa-associated lymphoid tissue lymphomas: more clues but still a puzzle (2010) (3)
Acute lymphoblastic leukemia: A study of 25 cases by scanning electron microscopy (1976) (3)
Establishment of the amsalem T‐cell line from a patient with acute lymphoblastic leukemia. Expression of E‐receptor‐associated antigens in cells incapable of forming E‐rosettes (1985) (3)
Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis (2013) (3)
Late Relapse in Hodgkin's Disease: Report of Five Cases and a Review of the Literature. (1991) (3)
Utilization of monoclonal antibodies and immuno-scanning electron microscopy for the positive identification of human leukemic cells (1983) (3)
Budd-Chiari syndrome in childhood: a study of two patients. (1971) (3)
Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy. (1979) (3)
Surface Morphology of Leukemic Cells as seen by Scanning Electron Microscopy (1984) (3)
Kaposi's sarcoma with chondrosarcoma of the tibia. (1970) (3)
Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlorodeoxyadenosine therapy: the spleen as a sanctuary site in HCL? (1994) (3)
Sustained haematological remission after bone marrow curettage in a case of primary myelofibrosis. (2009) (3)
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma (2020) (3)
Treatment of Hairy Cell Leukemia in its Second Half-Century: An International Conference on Hairy Cell Leukemia at the National Institutes of Health, April 26–27, 2010, Bethesda, MD (2011) (3)
Predicting time to first treatment in early stage CLL: scores, values and comparative prognostic models (2017) (2)
Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyond (2020) (2)
Treatment of experimental benign hyperkeratotic lesions of the hamster cheek pouch with topical vitamin A palmitate. (1971) (2)
Induction of plasmacytoid and hairy cell features by phorbol esters (TPA) in B‐lymphoma cells: Attempted correlation with disease activity (1988) (2)
Current perspectives regarding SARS‐CoV‐2 vaccination in chronic lymphocytic leukemia (2022) (2)
Chromosomal Abnormalities Detected by FISH in CLL May Be Influenced by Ethnic Origin: Preliminary Data from a Multicenter Study in Israel for the Israel CLL Study Group (ICLLSG). (2007) (2)
Absolute monocyte count identifies high-risk patients with lymphomas: “absolutely” simple and “counts” mean a lot! (2012) (2)
Historical aspects and milestones in the development of effective treatment for hairy cell leukemia (2009) (2)
T-cell prolymphocytic leukemia: survival improves with alemtuzemab, but stem cell transplant eligibility ‘counts’ even more (2016) (2)
Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials (2021) (2)
Human leukemias : cytochemical and ultrastructural techniques in diagnosis and research (1984) (2)
Human peripheral blood mononuclear cells cultured in serum-free medium: a functional and morphological study using light and scanning electron microscopy. (1984) (2)
Multifocal osteolytic lesions in hairy cell leukemia—the importance of PET/CT in diagnosis and assessment (2020) (2)
Chemoimmunotherapy with fludarabine, cytoxan and rituximab regimen: to use, not to use, or give it as “FCR-LITE”? (2014) (2)
Review and General Details of the Techniques Employed to Prepare Leukocytes (1977) (2)
The tumor necrosis factor family and and correlation with disease activity and response to treatment in hairy cell leukemia. (1999) (2)
A light and electron microscopic study of the lymphomyeloid complex in hypervitaminosis A. (1972) (2)
Chronic lymphocytic leukaemia and other leukaemias of mature B and T cells (2010) (2)
Mantle cell lymphoma: curcumin nanodisks and possible new concepts on drug delivery for an incurable lymphoma (2011) (2)
Progressive transformation of germinal centers and Hodgkin lymphoma: more insights but maybe more confusion? (2011) (2)
Cytochemistry and ultrastructure in lymphoma and leukemia: Utility in the diagnosis of different leukemias and the recognition of subtypes of lymphoproliferative disorders (2007) (2)
Cancer microenvironment, extracellular matrix, and adhesion molecules: the bitter taste of sugars in chronic lymphocytic leukemia (2011) (2)
Topical modes in the preparation of human spleen specimens for routine scanning electron microscopy studies. (1986) (2)
Surface morphology of leukemic cells: application of scanning electron microscopy to the study of human leukemias. (1977) (2)
Chronic lymphocytic leukemia is becoming more complex: how to define complex karyotype? (2018) (2)
Hodgkin's Lymphoma: Results of ABVD Chemotherapy in 40 Patients with Advanced or Bulky Disease. (1990) (2)
Surface morphology of cultured myeloma cells: bleb formation in cell variants with defects in immunoglobulin production and secretion. (1978) (2)
Observations on the Effect of Thymectomy or Chemical Carcinogenesis in the Hamster Cheek Pouch (1972) (2)
Risk factors for melanoma among survivors of non-Hodgkin lymphoma in the U.S. elderly population. (2014) (2)
Acute myeloid leukemia with 11q23/MLL rearrangement after ‘FCR’ regimen for chronic lymphocytic leukemia (2012) (2)
12-0-Tetradecanoyl Phorbol-13-Acetate (TPA) and Its Effect on Leukaemic Cells, In-vitro-A Review. (1990) (2)
Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients (2015) (2)
When and how to perform surveillance imaging in patients with lymphoma, and is it worth it? (2012) (2)
Unusual cytomegalovirus complications after autologous stem cell transplantation for large B cell lymphoma: massive gastrointestinal hemorrhage followed by a communicating hydrocephalus (2002) (2)
Increased Incidence of Rous Sarcomas in Response to Excess Vitamin A (1971) (2)
Carbamazepine-induced generalized "pseudoleukemia lymphoma"--like syndrome. (2003) (2)
Anti—IL2R Immunotoxins (1994) (2)
Effects of retinoic acid and phorbol ester on lymphocytes and monocytes in B-lymphocytic leukemia. (1988) (2)
Altered function and membrane properties of lymphocytic leukemia cells. Correlation with clinical stage of disease. (1982) (2)
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia (2022) (2)
Results of therapy in adult acute nonlymphoblastic leukemia: experience in Jerusalem, Israel, during 1975-1982. (1985) (2)
Acute Promyelocytic Leukemia in Childhood (1979) (2)
Scanning immuno-electron microscopy of a monoclonal, Epstein-Barr Virus(EBV) transformed human cell line producing rheumatoid factor in-vitro. (1983) (2)
Efficacy and Safety of Frontline Therapy with FCR Regimen for Chronic Lymphocytic Leukemia Outside Clinical Trials: Israeli CLL Study Group Experience (2014) (2)
Rituximab in space: intrapleural and other novel routes of administration for lymphomas and lymphoid leukemias (2012) (2)
Regulatory T cells in chronic lymphocytic leukemia: some progress and a bit of “tolerance” in understanding disease progression (2013) (1)
B-Type Lymphocytic Leukaemia Developing Seven Years after Chemoradiotherapy for Hodgkin's Disease: Report of a Case and Review of the Literature. (1990) (1)
Acridinyl anisidide (m-AMSA) therapy in 11 patients with refractory acute leukemia. (1984) (1)
FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes (2011) (1)
Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia (2021) (1)
Cancer Registries Often Underestimate the True Incidence of CLL (2014) (1)
Scanning immunoelectron microscopy markers. (1979) (1)
Myocardial telangiectases in hereditary hemorrhagic telangiectasia. (1986) (1)
Marginal zone lymphomas: Reconsidering similarities and differences while moving towards personalized treatment. (2017) (1)
Fludarabine Monophosphate, an Effective New Agent in Leukaemias and Lymphomas (1995) (1)
‘Hairy’ cells: where are the roots of this leukemia? (2011) (1)
Interim and end-treatment positron emission tomography scan in aggressive B-cell lymphoma: we still lack an interpretation key (2014) (1)
Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic leukemia (2022) (1)
Traumatic closed iliac bone biopsy defect simulating involvement by Hodgkin's disease. (1988) (1)
Basophils go wild when mosquitoes bite CLL (2016) (1)
Posttransplant lymphoproliferative disorder after living donor liver transplant: are we improving incidence and outcome? (2010) (1)
De novo acute myeloid leukemia with near-pentaploidy: diploid karyotype and lymphoblastic phenotype at relapse. (1997) (1)
Quantitation of Zap-70 Expression in B-CLLCells Employing a Novel Flow Cytometry Analysis Method. (2004) (1)
Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen (2020) (1)
Transient pancytopenia (1990) (1)
Sezary syndrome presenting with tumourous involvement of the breast detected by 18F‐fluorodeoxyglucose positron‐emission tomography/computed tomography (2012) (1)
2007: The year in review for Leukemia and Lymphoma (2008) (1)
Advances in chronic lymphocytic leukemia : proceedings from the 5th International Workshop on Chronic Lymphocytic Leukemia, Sitges (Barcelona), Spain, April 1991 (1991) (1)
Chlorambucil in indolent mantle cell lymphoma – just another old drug for a new disease? (2011) (1)
Hairy cell leukemia associated with carcinoma: Report of two patients and review of the literature (1985) (1)
Staging chronic lymphocytic leukemia (CLL) for prognosis at diagnosis (2006) (1)
Myeloma cells: surface morphology as seen by scanning and transmission electron microscopy. (1979) (1)
Risk of Second Malignancies after Non Hodgkin Lymphoma: A Cohort Study of 22,466 Survivors in Israel (2014) (1)
The effect of castration on chemical carcinogenesis in the cheek pouch of the male Syrian golden hamster. (1969) (1)
Acute myeloblastic leukemia following treatment with mitomycin C: a case report (2004) (1)
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia. (2019) (1)
Abstract LB-184: Risk factors for lung cancer among survivors of non-Hodgkin lymphoma (2015) (1)
Letter: Scanning electron microscopy of hairy cells in hairy-cell leukaemia. (1974) (1)
Microvesicles in chronic lymphocytic leukemia: ready for prime time in the clinic? (2017) (1)
Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project. (2012) (1)
Elevated soluble CD 27 levels (TNF-receptor) may predict survival in diffuse large B-cell lymphoma - revisiting “the super- family “ saga. (2012) (1)
Lysosomal enzymes and their relation to the distribution and resorption of experimental amyloid. (1972) (1)
Acute Monoblastic Leukemia with t(9;11) in a Patient Receiving Chemotherapy for Ovarian Cancer: Secondary Leukemia or Fortuitous Association of Two Neoplasias? (1991) (1)
Traumatic hemolysis after aortofemoral bypass. A study of 25 cases. (1977) (1)
Introduction and Methods (1977) (0)
Contents Vol. 68, 1982 (1982) (0)
Happy anniversary to the 10th International Conference on Malignant Lymphoma in Lugano, 4–7 June 2008With a personal tribute to the conference president and founder – Professor Franco Cavalli (2008) (0)
This information is current as with Disease Progression Lymphocytic Leukemia, Which Correlates Unfolds Intraclonal Diversity in Chronic Divergence in CD19-Mediated Signaling (2012) (0)
Neutrophil to Lymphocyte Ratio at Diagnosis Is an Independent Prognostic Factor in Diffuse Large B-Cell Lymphoma: Results of a Large Multicenter Study Involving 931 Patients (2015) (0)
Spontaneous partial regression of9-10 dimethyl 1-2 benzanthracene-induced epithelial atypia in the hamster cheek pouch. (1968) (0)
Chronic lymphocytic leukemia associated with systemic lupus erythematosus. (1991) (0)
Suppl-Resonate-2-Burger-2015 (2016) (0)
Subject Index Vol. 68, 1982 (1982) (0)
The Integration of Efficacy and Safety Outcomes Identifies the Net Clinical Benefit of Targeted Agents in Upfront Therapy of Chronic Lymphocytic Leukemia: Results of Network Meta-Analysis (2022) (0)
Mitogen-Transformed Lymphocytes (1977) (0)
Simultaneous multiple labelling of cells using mixtures of different antibody-latex conjugates and immuno-scanning electron microscopy (immuno-SEM) (1984) (0)
Labeling Studies on Lymphocytes (1977) (0)
A Novel Risk-Model to Predict Time to First Treatment (TTT) in Chronic Lymphocytic Leukemia Based on Heavy+Light Chain Immunoparesis and Serum Free Light Chain Analysis: Results from the Israeli CLL Study Group (2018) (0)
Errata (2009) (0)
Author response for "A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents" (2021) (0)
The contribution of transmission and scanning electron microscopy in the diagnosis of human leukemias: Current status (1984) (0)
The effect of testosterone on chemical carcinogenesis in the buccal pouches of castrated and intact male hamsters. (1970) (0)
Immuno-Scanning Electron Microscopy of Human Leukemic Cells (1984) (0)
[Hodgkin's disease: histologic subtypes and survival rates]. (1979) (0)
Lenalidomide and T-cell homeostasis: tolerating immune reconstitution after autologous stem cell transplant (2014) (0)
A novel way to consolidate incomplete responses in chronic lymphocytic leukemia/small lymphocytic lymphoma (2016) (0)
Advances in Chronic Lymphocytic Leukemia (1992) (0)
3.16 Increased Incidence of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in Patients with Merkel Cell Carcinoma in Israel (2011) (0)
Subject Index, Vol. 62, 1979 (1979) (0)
Benign and Malignant Lymphadenopathies. Clinicaland Laboratory Diagnosis. Harwood Academic Publishers, Berlin/Heidelberg/New York (1993) (1998) (0)
[Nervous system involvement in malignant lymphoma]. (1982) (0)
The 5 Th InTernaTIonal Workshop on posITron emIssIon Tomography In lymphoma Report on the 5 th International Workshop on Positron Emission Tomography in Lymphoma held in Menton , France , 19 – 20 September 2014 (2015) (0)
Preparation of cells for scanning em using tannic acid-osmium and air drying (AD); a new AD approach compared with critical point drying (1982) (0)
The enigma of LAG3 receptor in hematological malignancies (2022) (0)
cyclophosphamide prolongs progression-free survival in high-risk CLL Frontline low-dose alemtuzumab with fludarabine (2014) (0)
Author response for "Improving the IPI score using peripheral blood counts: results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma" (2020) (0)
T-cell depleted bone marrow transplantation for plasma cell myeloma (1988) (0)
Diatom Frustules as Substrates for Photocatalysts (2018) (0)
Splenic lymphoma in a patient treated with interleukin-2 and dacarbazine for metastatic melanoma. (1992) (0)
Subject Index, Vol. 71, 1984 (1984) (0)
Professors Amiram Eldor and Yaakov Matzner. In Memory of Two Dear Friends and Colleagues (2002) (0)
CLL and CML sometimes meet and circulate together (2019) (0)
Acute promyelocytic leukemia in childhood. Report of a case with a review of the literature. (1979) (0)
Erratum: Evidence of time‐dependent prognostic factors predicting early death but not long‐term outcome in primary CNS lymphoma: a study of 91 patients (2013) (0)
Surface Features of Sézary Cells (1979) (0)
Absolute Monocyte Count At Diagnosis Is a Poor Prognostic Factor and Impacts Survival in Diffuse Large B-Cell Lymphoma: A Collaborative Multi-Center Study Involving 1026 Patients. (2012) (0)
Contents, Vol. 62, 1979 (1979) (0)
A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group. (2004) (0)
Follicular lymphoma: is peripheral blood involvement still an adverse prognostic factor in the rituximab era? (2015) (0)
Phase 3 Study of Ibrutinib versus Chlorambucil in Patients ≥65 Years with Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (2016) (0)
Report of the International Splenic Lymphoma Study Group meeting held in 2019 in Barcelona, Spain (2020) (0)
Dr Bloom and colleagues respond (1996) (0)
New editorial team on leukemia and lymphoma (2006) (0)
International, randomized phase 3 study results : Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM)) (2016) (0)
Intra-Clonal Diversity Identified by CD19-Mediated Signaling Correlates with Disease Progression In Chronic Lymphocytic Leukemia (CLL) (2010) (0)
Bone marrow fibrosis: a prognostic scar in hematological malignancies (2013) (0)
Book Review / News (1968) (0)
Absolute Monocytosis At Diagnosis Is Associated with Poor Survival in Diffuse Large B-Cell Lymphoma -Possibly Related to Increase in Monocytic-Myeloid Derived Suppressor Cells (2011) (0)
High Risk Advanced Stage Hodgkin Lymphoma Is Well Controlled with 2 Cycles of Escalated Beacopp Followed By 4 Cycles of ABVD in Patients Who Rapidly Achieve Metabolic CR on Interim PET/CT Scan (2014) (0)
Detection of ZAP70 Negative B-CLL Patients Using the Beckman Coulters Positional Parameter Technology and RPD (Research Population Data) Analysis. (2006) (0)
Results of a Phase II of Low-Dose Fludarabine and Cyclophosphamide Combined with Standard Dose Rituximab (FCR-LITE) in Elderly, Untreated Patients with Chronic Lymphocytic Leukemia (CLL): The Israeli CLL Study Group Experience (2018) (0)
2.7 Intra-Clonal Diversity Identified by CD19-Mediated Signaling Correlates with Disease Progression in CLL (2011) (0)
Divergence in CD19-Mediated Signaling Unfolds Intra-Clonal Diversity in Chronic Lymphocytic Leukemia Which Correlates with Disease Progression (2012) (0)
External Validation of a Novel Risk Model (BALL Score) in Real-World Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib. a Campus CLL Study (2019) (0)
Blastic Transformation of Chronic Granulocytic Leukemia and other Myeloproliferative Disorders (1984) (0)
Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg (2019) (0)
Defining the appropriate starting dose of lenalidomide in chronic lymphocytic leukemia: remember the old fable of the hare and the tortoise (2016) (0)
Editorial (2005) (0)
Erratum: Absolute monocytosis at diagnosis correlates with survival in diffuse large B‐cell lymphoma—possible link with monocytic myeloid‐derived suppressor cells (2013) (0)
The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: are all purine analogs created equal? (2010) (0)
Diffuse large cell non-Hodgkin's lymphoma: results of M-BACOD combination chemotherapy. (1988) (0)
Fludarabine in the treatment of refractory lymphocytic leukemia (CLL) and low grade lymphoma (LGL) (1993) (0)
A Distributed International Patient Data Registry for Hairy Cell Leukemia (2016) (0)
Electronmicroscopy of leukaemic myeloblasts with numerous lipid-containing vacuoles. (2009) (0)
The Location of Multiple Myeloma Adhesion Variants in Diverse Niches within the Bone Marrow Affects Plasma Cells Enumeration. (2006) (0)
RED BLOOD CELL MEMBRANE DEFECTS IN β THALASSEMIA AND THE THERAPEUTIC ROLE OF α-TOCOPHEROL (VITAMIN E) (1979) (0)
Is ibrutinib the gold standard for therapy – naive elderly patients with CLL? (2022) (0)
Surface features of Sézary cells. A scanning electron microscopy study. (1978) (0)
Contents, Vol. 71, 1984 (1984) (0)
David Galton – a friend and teacher (2007) (0)
Heparanase expression is prevalent in AML but not in lymphoid malignancies (2000) (0)
Rituximab-Related Pulmonary Toxicity (2010) (0)
Erratum: Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions (2013) (0)
Leukemia & lymphoma reviews (1997) (0)
CHRONIC LYMPHOID LEUKAEMIAS : BASIC DIAGNOSIS AND TREATMENT (1995) (0)
Professor Daniel Catovsky 19 September 1937-2 December 2022. (2023) (0)
Richter’s Syndrome In Chronic Lymphocytic Leukemia: Clinical and Laboratory Features In 119 Patients, Attempting To Identify Possible Risk Factors (2013) (0)
Other Factors Influencing the Surface Morphology of Lymphocytes and Mammalian Cells (1977) (0)
Evidence-based Anticancer Materia Medica for Lymphoma (2012) (0)
Treating chronic lymphocytic leukemia with a combination of rituximab and alemtuzumab: a “successful couple,” but are they still relevant together? (2015) (0)
Successful therapy in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine (2CdA) - single institute experience (1993) (0)
Chronic Lymphocytic Leukemia Cells by Glucocorticoids Lysis of in Vitro Metabolic and Ultrastructural Aspects of the Updated (2006) (0)
The Frequency and Prognostic Value of Neutrophilia in Chronic Lymphocytic Leukemia (2018) (0)
Ibrutinib vs Clorambucilo-Burger-2015-e-pub (2016) (0)
Editorial Comment. (1989) (0)
Statement of Retraction: Huang H, Wu D, Fu J, Chen G. “Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid” (2014) (0)
The net clinical benefit of targeted agents in the upfront treatment of elderly/unfit chronic lymphocytic leukemia patients: Results of network meta‐analysis (2023) (0)
Cold Urticaria: An Unusual Manifestation of Histiocytic (2016) (0)
Concanavalin A receptors on the surface membrane of lymphocytes from patients with acute leukemia. (1984) (0)
Chronic lymphocytic leukaemia (2010) (0)
The effect of membrane-active agents on the mitotic frequency in normal and carcinogen-treated epithelium (1972) (0)
The challenge of unavailable IGH mutational status in CLL in resource-limited settings (2020) (0)
Increased CD39 Expression on CD4+ T-Lymphocytes Has Clinical and Prognostic Significance in Chronic Lymphocytic Leukemia, (2011) (0)
Case report: Coexistent chronic myeloid leukemia and IgA monoclonal gammopathy report of a case and review of the literature (1980) (0)
Solitary chloroma (1984) (0)
Comparison of the relative sensitivity and efficiency of immuno-scanning electron microscopy (immuno-SEM) and immunofluorescence (immuno-FL) (1984) (0)
The Involvement of LAG3+ Plasma Cells in the Development of Multiple Myeloma (2022) (0)
[Acute myeloid leukemia: a late complication of the treatment for Hodgkin's disease]. (1983) (0)
Shiga-like Toxin Producing E. coli Identified in Patients with Multiple Myeloma (MM) Hospitalized Due to Acute Onset Diarrhea; First Report on the Clinical Use of the Biofire Film Array Gastrointestinal Panel (2018) (0)
CML and tyrosine kinase inhibition: the hope becomes reality (2015) (0)
Membrane properties and surface morphology of cell lines derived from patients with lymphoma, leukemia and infectious mononucleosis. (1979) (0)
CORRELATIONS BETWEEN ELEVATED SERUM FERRITINE LEVEL AND INITIAL CHARACTERISTICS OF HODGKIN ’ S LYMPHOMA PATIENTS (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Aaron Polliack?

Aaron Polliack is affiliated with the following schools: